AIM ImmunoTech Inc. (AIM) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

AIM ImmunoTech Inc. (AIM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.4M, listed on AMEX, employing roughly 21 people, carrying a beta of 1.24 to the broader market. AIM ImmunoTech Inc. Led by Thomas K. Equels, public since 1995-11-02.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for AIM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →